| 719808 |
FRONTIERS IN ONCOLOGY |
Prognostic and Immunological Role of Gasdermin E in Pan-Cancer Analysis |
2021-07-26 |
10.3389/fonc.2021.706266 |
Zhang Zheng, Zhao Shuangshuang, Yang Haizhen, Chen Yanwei, Feng Huahui, An Maohui, Chen Baoding |
| 719807 |
FRONTIERS IN ONCOLOGY |
The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience |
2021-07-26 |
10.3389/fonc.2021.687730 |
Karol Dalia, McKinnon Mathieu, Mukhtar Lenah, Awan Arif, Lo Bryan, Wheatley-Price Paul |
| 719806 |
FRONTIERS IN ONCOLOGY |
The COX10-AS1/miR-641/E2F6 Feedback Loop Is Involved in the Progression of Glioma |
2021-07-26 |
10.3389/fonc.2021.648152 |
Liu Liang, Li Xiaojian, Wu Heming, Tang Yong, Li Xiang, Shi Yan |
| 719805 |
FRONTIERS IN ONCOLOGY |
Case Report: Circulating Tumor DNA Fraction Analysis Using Ultra-Low-Pass Whole-Genome Sequencing Correlates Response to Chemoradiation and Recurrence in Stage IV Small-Cell Carcinoma of the Cervix - A Longitudinal Study |
2021-07-26 |
10.3389/fonc.2021.652683 |
Abbas Ata, Gruner Morgan, Karohl Jennifer, Rose Peter G., Joehlin-Price Amy, Stover Daniel, Mahdi Haider |
| 719804 |
FRONTIERS IN ONCOLOGY |
FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML |
2021-07-26 |
10.3389/fonc.2021.696532 |
Chesnokov Mikhail S, Borhani Soheila, Halasi Marianna, Arbieva Zarema, Khan Irum, Gartel Andrei L. |
| 719803 |
FRONTIERS IN ONCOLOGY |
PHF6 Mutations in Hematologic Malignancies |
2021-07-26 |
10.3389/fonc.2021.704471 |
Kurzer Jason H., Weinberg Olga K. |
| 719802 |
FRONTIERS IN ONCOLOGY |
Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4 |
2021-07-26 |
10.3389/fonc.2021.735447 |
He Xi, Sun Huiwei, Jiang Qiyu, Chai Yantao, Li Xiaojuan, Wang Zhijie, Zhu Bing, You Shaoli, Li Boan, Hao Junfeng, Xin Shaojie |
| 719801 |
FRONTIERS IN ONCOLOGY |
Assistance by Routine CT Features Combined With 3D Texture Analysis in the Diagnosis of BRCA Gene Mutation Status in Advanced Epithelial Ovarian Cancer |
2021-07-26 |
10.3389/fonc.2021.696780 |
Li Meng-ru, Liu Ming-zhu, Ge Ya-qiong, Zhou Ying, Wei Wei |
| 719800 |
FRONTIERS IN ONCOLOGY |
m6A Modification: A Double-Edged Sword in Tumor Development |
2021-07-26 |
10.3389/fonc.2021.679367 |
Gao Runnan, Ye Mujie, Liu Baihui, Wei Meng, Ma Duan, Dong Kuiran |
| 719799 |
FRONTIERS IN ONCOLOGY |
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study |
2021-07-26 |
10.3389/fonc.2021.695038 |
Jantus-Lewintre Eloisa, Massutí Sureda Bartomeu, González Larriba José Luis, Rodríguez-Abreu Delvys, Juan Oscar, Blasco Ana, Dómine Manuel, Provencio Pulla Mariano, Garde Javier, Álvarez Rosa, Maestu Inmaculada, Pérez de Carrión Ramón, Artal Ángel, Rolfo Christian, de Castro Javier, Guillot Mónica, Oramas Juana, de las Peñas Ramón, Ferrera Lioba, Martínez Natividad, Serra Òlbia, Rosell Rafael, Camps Carlos |
